These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 22411600)
1. Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels. Kisim A; Atmaca H; Cakar B; Karabulut B; Sezgin C; Uzunoglu S; Uslu R; Karaca B J Cancer Res Clin Oncol; 2012 Jul; 138(7):1155-63. PubMed ID: 22411600 [TBL] [Abstract][Full Text] [Related]
2. Caudatin potentiates the anti-tumor effects of TRAIL against human breast cancer by upregulating DR5. Fei HR; Yuan C; Wang GL; Zhao Y; Li ZJ; Du X; Wang FZ Phytomedicine; 2019 Sep; 62():152950. PubMed ID: 31102888 [TBL] [Abstract][Full Text] [Related]
3. Anti-tumor Effects of IL-1β Induced TRAIL-Expressing hUCMSCs on Embelin Treated Breast Cancer Cell Lines. Teng JW; Hung E; Wu JM; Liang YH; Chiu YH; Tyan YS; Wang HS Asian Pac J Cancer Prev; 2023 Apr; 24(4):1297-1305. PubMed ID: 37116152 [TBL] [Abstract][Full Text] [Related]
4. Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells. Yan S; Qu X; Xu L; Che X; Ma Y; Zhang L; Teng Y; Zou H; Liu Y Anticancer Drugs; 2014 Jul; 25(6):683-9. PubMed ID: 24710190 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation. Kim SY; Hong M; Heo SH; Park S; Kwon TK; Sung YH; Oh Y; Lee S; Yi GS; Kim I Mol Carcinog; 2018 Nov; 57(11):1492-1506. PubMed ID: 29964331 [TBL] [Abstract][Full Text] [Related]
6. Notch inhibition restores TRAIL-mediated apoptosis via AP1-dependent upregulation of DR4 and DR5 TRAIL receptors in MDA-MB-231 breast cancer cells. Portanova P; Notaro A; Pellerito O; Sabella S; Giuliano M; Calvaruso G Int J Oncol; 2013 Jul; 43(1):121-30. PubMed ID: 23686163 [TBL] [Abstract][Full Text] [Related]
7. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5. Zhang Y; Zhang B Mol Cancer Res; 2008 Dec; 6(12):1861-71. PubMed ID: 19074831 [TBL] [Abstract][Full Text] [Related]
8. Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade. Das S; Tripathi N; Preet R; Siddharth S; Nayak A; Bharatam PV; Kundu CN Oncotarget; 2017 Jan; 8(1):248-267. PubMed ID: 27542249 [TBL] [Abstract][Full Text] [Related]
9. Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL. Sung B; Ravindran J; Prasad S; Pandey MK; Aggarwal BB J Biol Chem; 2010 Nov; 285(46):35418-27. PubMed ID: 20837473 [TBL] [Abstract][Full Text] [Related]
10. α-TEA induces apoptosis of human breast cancer cells via activation of TRAIL/DR5 death receptor pathway. Yu W; Tiwary R; Li J; Park SK; Jia L; Xiong A; Simmons-Menchaca M; Sanders BG; Kline K Mol Carcinog; 2010 Nov; 49(11):964-73. PubMed ID: 20886583 [TBL] [Abstract][Full Text] [Related]
11. Licochalcone D exhibits cytotoxicity in breast cancer cells and enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis through upregulation of death receptor 5. Zhang Y; Wang L; Dong C; Zhuang Y; Hao G; Wang F J Biochem Mol Toxicol; 2024 Jul; 38(7):e23757. PubMed ID: 38937960 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells. Yan S; Qu X; Xu C; Zhu Z; Zhang L; Xu L; Song N; Teng Y; Liu Y J Cancer Res Clin Oncol; 2012 Aug; 138(8):1279-89. PubMed ID: 22447040 [TBL] [Abstract][Full Text] [Related]
13. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Nimmanapalli R; Perkins CL; Orlando M; O'Bryan E; Nguyen D; Bhalla KN Cancer Res; 2001 Jan; 61(2):759-63. PubMed ID: 11212279 [TBL] [Abstract][Full Text] [Related]
14. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. Singh TR; Shankar S; Chen X; Asim M; Srivastava RK Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373 [TBL] [Abstract][Full Text] [Related]
15. The essential role of the mitochondria-dependent death-signaling cascade in chemotherapy-induced potentiation of Apo2L/TRAIL cytotoxicity in cultured thoracic cancer cells: amplified caspase 8 is indispensable for combination-mediated massive cell death. Nguyen DM; Yeow WS; Ziauddin MF; Baras A; Tsai W; Reddy RM; Chua A; Cole GW; Schrump DS Cancer J; 2006; 12(4):257-73. PubMed ID: 16925970 [TBL] [Abstract][Full Text] [Related]
16. The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in breast cancer. Zhang N; Wang X; Huo Q; Li X; Wang H; Schneider P; Hu G; Yang Q J Biol Chem; 2013 Mar; 288(13):9396-407. PubMed ID: 23408429 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of Death Receptor 5 and Production of Reactive Oxygen Species Mediate Sensitization of PC-3 Prostate Cancer Cells to TRAIL Induced Apoptosis by Vitisin A. Shin D; Kwon HY; Sohn EJ; Nam MS; Kim JH; Lee JC; Ryu SY; Park B; Kim SH Cell Physiol Biochem; 2015; 36(3):1151-62. PubMed ID: 26111475 [TBL] [Abstract][Full Text] [Related]
18. A diverse induction of apoptosis by trabectedin in MCF-7 (HER2-/ER+) and MDA-MB-453 (HER2+/ER-) breast cancer cells. Atmaca H; Bozkurt E; Uzunoglu S; Uslu R; Karaca B Toxicol Lett; 2013 Aug; 221(2):128-36. PubMed ID: 23792433 [TBL] [Abstract][Full Text] [Related]
19. Combination of Ad-sTRAIL with the chemotherapeutic drug cisplatin synergistically enhances their pro-apoptotic ability in human breast cancer cells. Liu X; Wang J; Wang H; Liu S; Liang Y; Lv Z; Zhou Q; Ding W Oncol Rep; 2013 Oct; 30(4):1913-9. PubMed ID: 23912708 [TBL] [Abstract][Full Text] [Related]
20. Short-hairpin RNA-induced suppression of adenine nucleotide translocase-2 in breast cancer cells restores their susceptibility to TRAIL-induced apoptosis by activating JNK and modulating TRAIL receptor expression. Jang JY; Jeon YK; Choi Y; Kim CW Mol Cancer; 2010 Sep; 9():262. PubMed ID: 20875141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]